BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/28/2021 9:18:59 AM | Browse: 233 | Download: 403
 |
Received |
|
2021-08-18 04:44 |
|
Peer-Review Started |
|
2021-08-18 04:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-06 07:59 |
|
Revised |
|
2021-11-13 17:54 |
|
Second Decision |
|
2021-12-24 04:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-24 08:20 |
|
Articles in Press |
|
2021-12-24 08:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-12-14 10:02 |
|
Typeset the Manuscript |
|
2021-12-26 15:41 |
|
Publish the Manuscript Online |
|
2021-12-28 09:18 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Clinical Neurology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Efficacy and safety of fingolimod in stroke: A systemic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kai Zhao, Yu Guo, Ming-Fei Yang and Qiang Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Project of Science and Technology Department of Qinghai Province |
2020-ZJ-774 |
| National Key R&D Program of China |
2018YFC1312601 |
|
| Corresponding Author |
Qiang Zhang, MD, PhD, Chief Doctor, Surgeon, Department of Neurosurgery, Qinghai Provincial People's Hospital, No. 2 Gonghe Road, Xining 810007, Qinghai Province, China. zhangqiang691212@163.com |
| Key Words |
Acute ischemic stroke; Intracerebral hemorrhage; Fingolimod; Meta-analysis; Treatment |
| Core Tip |
Brain tissue injury in stroke patients involves inflammation around the infarction lesion or hematoma, which is an important reason for disease deterioration and can result in a poor prognosis. Our systemic review and meta-analysis of recent randomized controlled trials found that fingolimod might improve neurological function in stroke patients by reducing lymphocyte infiltration in the brain effectively; however, we did not find the evidence that fingolimod could promote infarction lesion or hematoma absorption. In general, oral fingolimod (0.5 mg/d, 3 consecutive days) was safe in stroke patients except for some rare severe adverse events. |
| Publish Date |
2021-12-28 09:18 |
| Citation |
Zhao K, Guo Y, Yang MF, Zhang Q. Efficacy and safety of fingolimod in stroke: A systemic review and meta-analysis. World J Meta-Anal 2021; 9(6): 585-597 |
| URL |
https://www.wjgnet.com/2308-3840/full/v9/i6/585.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v9.i6.585 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
